Detalhe da pesquisa
1.
Bim is the key mediator of glucocorticoid-induced apoptosis and of its potentiation by rapamycin in human myeloma cells.
Biochim Biophys Acta
; 1803(2): 311-22, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19914305
2.
The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism.
Oncotarget
; 6(22): 19228-45, 2015 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26231043
3.
Chemical metabolic inhibitors for the treatment of blood-borne cancers.
Anticancer Agents Med Chem
; 14(2): 223-32, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24237221
4.
Extracellular-signal-regulated kinase 5 modulates the antioxidant response by transcriptionally controlling Sirtuin 1 expression in leukemic cells.
Int J Biochem Cell Biol
; 53: 253-61, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24880091
5.
All-trans retinoic acid (ATRA) induces miR-23a expression, decreases CTSC expression and granzyme B activity leading to impaired NK cell cytotoxicity.
Int J Biochem Cell Biol
; 49: 42-52, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24440757
6.
From tumor cell metabolism to tumor immune escape.
Int J Biochem Cell Biol
; 45(1): 106-13, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22568930
7.
Different contribution of BH3-only proteins and caspases to doxorubicin-induced apoptosis in p53-deficient leukemia cells.
Biochem Pharmacol
; 79(12): 1746-58, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20188077
8.
Cooperation between Apo2L/TRAIL and bortezomib in multiple myeloma apoptosis.
Biochem Pharmacol
; 77(5): 804-12, 2009 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19100720